The ADWP is dedicated to promoting clinical activities, teaching and translational research on autologous/allogeneic HSCT together with novel approaches of cellular therapy as specific treatment of severe Autoimmune Diseases (AD), in a specific challenge to re-induce self-tolerance by resetting the immune system.
The ADs section of the EBMT Registry is the largest database of its kind worldwide. ADs is recently facing a unique developmental phase across EBMT centres. Autologous HSCT has become an integral and standard-of-care part of treatment algorithms in multiple sclerosis (MS) and systemic sclerosis (SSc). Recently, novel cellular therapies (ie CART cells, mesenchymal cells) have been successfully adopted in ADs.
A multidisciplinary approach is key in this field, and the ADWP has the strategic task of interacting with other Autoimmune Diseases (AD) specialists and their respective scientific societies.
ADWP Team
![Tobias Alexander Tobias Alexander](/sites/default/files/styles/member/public/migration_legacy_files/team_member/Alexander%20Tobias%20EBMT%20European%20Society%20for%20Blood%20and%20Marrow%20Transplantation.jpg?h=9f017ce1&itok=rq4BZ3ib)
![Elisa Roldan-Galvan](/sites/default/files/styles/member/public/images/team_member/Elisa%20Roldan-Galvan.png?h=9f017ce1&itok=sXLkNk1_)
![Ariadna Domènech, new Autoimmune Diseases Working Party Nurse Ariadna Domènech, new Autoimmune Diseases Working Party Nurse](/sites/default/files/styles/member/public/images/team_member/Ariadna%20Dom%C3%A8nech.jpg?h=9f017ce1&itok=JR8zCihT)
![Pascale Ambron Pascale Ambron](/sites/default/files/styles/member/public/images/team_member/Pascale%20Ambron.jpg?h=9f017ce1&itok=N9wgbqRB)